Press Release
Bimeda to Become Exclusive Distributor of Equell™ and Equimax®
OAKBROOK, Illinois and CAMBRIDGE, Ontario (October 1, 2009) – Bimeda announced it will become the exclusive U.S. and Canadian distributor of, Equell™ (ivermectin) Paste and Equimax® (ivermectin & praziquantel) Paste, manufactured by Virbac Corporation, effective today.
Both products complement the growing line of equine products already marketed by Bimeda in the United States, including Bimectin® (ivermectin) Paste 1.87% and Exodus® (pyrantel pamoate) Paste anthelmintics. Additional products within Bimeda´s equine category include Butatron®(phenylbutazone) Tablets, Dexium® (dexamethasone) 2mg/mL Injection, Dexium®–SP™ (dexamethasone sodium phosphate 4 mg), Flunazine® (flunixin meglumine) Injectable Solution, Fura–Septin™ (Nitrofurazone) Ointment, Hypertonic Saline Solution 7.2%, Lactated Ringer´s Injection, USP and Pro-Pen-G® (Penicillin G procaine) Suspension.
About Bimeda
Bimeda, Inc. is a leading manufacturer of a variety of novel and generic animal health pharmaceutical dosage forms produced in three FDA approved manufacturing plants throughout North America. The company is headquartered in Oakbrook Terrace, IL.
For more information, visit www.bimedaus.com in the U.S. or www.bimedamtc.com in Canada.
News Media Contacts:
Bimeda
Alan Kelly
1–630–605–0080
Customer Support:
If you are a veterinarian, horse owner, or equine manager with a question about our products, please call Bimeda Inc. Product Support at 1–888–524–6332.
To ask a question regarding Bimeda Inc. products or report an adverse experience, human exposure, or product defect, please call 1–888–524–6332. Our hours of operation are Monday through Friday from 9 AM to 5 PM (ET).
Reference Materials
« Equimax® product resources. PDF and JPG files available for download.